Alabama Clinical Trials

Recruiting studies in Alabama

• A Study to Learn About the Monthly Dosing Study Medicine Called Berobenatide in Adults With Breathing Problems During Sleep and Overweight or Obesity Who Use a Breathing Machine (PAP) (VESPER-OSA 1)
  NCT07823608PHASE3PfizerApneaCullman, AL
• A Phase IIb Dose-ranging Study to Assess the Efficacy and Safety of GIA632 in Participants With Non-segmental Vitiligo
  NCT07431177PHASE2Novartis PharmaceuticalsNon-segmental VitiligoBirmingham, AL
• A 52-Week Trial to Investigate the Efficacy and Safety of Delgocitinib Cream in Adult Participants With Lichen Sclerosus
  NCT07335588PHASE3LEO PharmaLichen SclerosusBirmingham, AL
• A Clinical Study of Molnupiravir to Prevent Severe Illness From Coronavirus Disease 2019 (COVID-19) in People Who Are High Risk (MK-4482-023)
  NCT06667700PHASE3Merck Sharp & Dohme LLCCoronavirus Disease (COVID-19)Cullman, AL
• RAD 1802: Pilot Trial of Five Fraction Stereotactic Body Radiotherapy for Early Stage Breast Cancer Patients Eligible for Post-Operative Accelerated Partial Breast Irradiation (APBI)
  NCT03643861NAUniversity of Alabama at BirminghamBreast CancerBirmingham, AL
• Testing Short-Course Radiation Versus Standard-Course Radiation for Soft Tissue Sarcomas That Need Surgery and Radiation
  NCT07615049PHASE3SWOG Cancer Research NetworkRecurrent Soft Tissue Sarcoma of the Trunk and ExtremitiesBirmingham, AL
• Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)
  NCT05633654PHASE3Gilead SciencesTriple Negative Breast CancerBirmingham, AL
• A Study to Assess Adverse Events, How the Drug Moves Through the Body and Effectiveness of Intravenous Infusions and Subcutaneous Injections of ABBV-519 in Adult Participants With Systemic Lupus Erythematosus (SLE) or Rheumatoid Arthritis (RA)
  NCT07607964PHASE1AbbVieSystemic Lupus ErythematosusAnniston, AL
• MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
  NCT05564390PHASE2National Cancer Institute (NCI)Acute Myeloid LeukemiaBirmingham, AL
• A Study to Assess the Efficacy and Safety of GIA632 Across a Range of Doses in Participants With Moderate to Severe Cutaneous Lichen Planus
  NCT07775924PHASE2Novartis PharmaceuticalsCutaneous Lichen PlanusBirmingham, AL
• Nutrition for Precision Health, Powered by the All of Us
  NCT05701657NARTI InternationalNutritionBirmingham, AL
• Abbott Vascular Medical Device Registry
  NCT04573660Abbott Medical DevicesAcute Myocardial InfarctionBirmingham, AL

See all 1,227 recruiting trials →

Clinical trials by Alabama metro

• Birmingham

Popular conditions in Alabama

• Breast Cancer
• Prostate Cancer
• Lung Cancer
• Colorectal Cancer
• Obesity
• Type 2 Diabetes
• Depression
• Alzheimer Disease
• Heart Failure
• Multiple Sclerosis
• Rheumatoid Arthritis
• Asthma
• Non-small Cell Lung Cancer
• Small Cell Lung Cancer
• Pancreatic Cancer
• Pancreatic Ductal Adenocarcinoma

Frequently asked questions

How do I find clinical trials in Alabama?

Corterve aggregates actively recruiting clinical trials with sites in Alabama from the public ClinicalTrials.gov registry. Browse the studies on this page or take an assessment to find trials you may qualify for.

Are clinical trials in Alabama free to join?

Costs, travel support, and any payment for taking part vary by study. Ask the study team what is covered before you decide to join.

What kinds of clinical trials are available in Alabama?

Alabama research sites run studies across many areas including oncology, neurology, cardiology, and metabolic health. This page is general information and not medical advice; confirm any specific trial with your healthcare provider.